Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 393 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22133523_22133624dup |
| Variant | c.1303-?_1404+?dup |
| Variant Start Position | 1303 |
| Location | Intron 11 |
| Amino Acid Change | Gain (Exon 12) |
| ACMG Call | Pathogenic |
| ACMG Call Last Revised Date | 2022-02-02 00:00:00 |
| Predicted ACMG Call | - | Effect Type | Duplication |
| Variant Type | CNV |
| PMID | 34806794 |
| Article Count | 1 |
| Times Observed | 3-5 |
| Clinical Phenotype | Lower limb deformities, Reduced Serum Phosphate |
| ACMG Categories | - |
| ACMG Explanations | - |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | - |
| No Contrary Evidence Found | No |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | - |
| GnomAD Alleles | - |
| DBNSFP Alleles | - |
| Other Alleles | - |
| Note | nan |
| Warnings | - |